Browsing Tag
colorectal
Combining epigenetic cancer medications may have benefit for colorectal cancers and other tumor…
Credit: Unsplash/CC0 Public Domain
A pair of medications that make malignant cells act as if they have a virus could hold new promise for…
Biomedicines | Free Full-Text | Gut Microbiota Signatures with Potential Clinical Usefulness in…
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Biomedicines 2024, 12(3), 703; https://doi.org/10.3390/biomedicines12030703 (registering DOI)
Submission received: 30 January 2024
/…
Biomedicines | Free Full-Text | THZ2 Ameliorates Mouse Colitis and Colitis-Associated Colorectal…
Colorectal cancer is the fourth leading cause of death in cancer throughout the world, killing nearly 900,000 people each year, and can affect the quality of life through both the direct and indirect consequences of the disease .…
Cancers | Free Full-Text | A Comprehensive Understanding of Post-Translational Modification of Sox2…
1. IntroductionColorectal cancer (CRC) ranks as the third leading cause of cancer-related deaths worldwide , with a significant number of patients diagnosed at advanced stages characterized by treatment resistance, recurrence, and…
CRCbioscreen Announces Positive Results of Population-Based mtFIT Study for Early Detection of…
Relative performance of mtFIT compared to FIT
The mtFIT test detected more advanced adenomas than FIT, indicating that mtFIT could be more effective in population based colorectal cancer screening
AMSTERDAM, NETHERLANDS, February…
Disparities in Colorectal Cancer Incidence among Asian and Pacific Islander Populations in Guam,…
1. IntroductionColorectal cancer (CRC) is the second leading cause of cancer-related deaths worldwide and ranks among the three most common cancers in Guam (GU) , Hawai’i (HI) , and the mainland United States (US) . In these areas, CRC…
Salk scientists uncover how high-fat diets drive colorectal cancer growth – Salk Institute for…
February 21, 2019
Salk scientists uncover how high-fat diets drive colorectal cancer growth
Experimental drug…
Blocking epigenetic “Swiss army knife” may be a new strategy for treating colorectal cancer
GRAND RAPIDS, Mich. (April 4, 2019) — A new study out today in Cancer Cell shows that blocking specific regions of a protein called UHRF1 switches on hundreds of cancer-fighting genes, impairing colorectal cancer cells’ ability to…
Cancers | Free Full-Text | Biomarker Analysis from a Phase I/Ib Study of Regorafenib and Nivolumab…
4. DiscussionAlthough immune checkpoint inhibitors demonstrated remarkable anticancer activity in MSI-H/dMMR colorectal cancer , they failed to show any clinical benefit in MSS/pMMR colorectal cancer, which is over 90% of colorectal…
JPM | Free Full-Text | The Impact of Chemotherapy and Transforming Growth Factor-β1 in Liver…
1. BackgroundThe colorectal cancer (CRC) incidence rate is growing. It is the third most common and second deadliest malignancy worldwide, with more than 1.9 million new cases and 935,000 cancer-related deaths annually . Recent…
Machine learning-based classifiers to predict metastasis in colorectal cancer patients
Background
Colorectal cancer (CRC) has been regarded as one of the four most common types of cancer as well as the second leading cause of cancer deaths (Siegel et al., 2016). While there have been promising advancements in reducing the…
Improving Guideline-Recommended Colorectal Cancer Screening in a Federally Qualified Health Center…
1. IntroductionColorectal cancer (CRC) screening is effective in both the prevention and early detection of colon cancer, yet CRC continues to be one of the most common cancers diagnosed in both men and women in the United States (US),…
Cancers | Free Full-Text | The Association between Red Meat Consumption and Advanced Colorectal…
1. IntroductionColorectal cancer (CRC) is the fourth-most diagnosed cancer in Canada, accounting for approximately 10% of all cancer cases. It was estimated that 24,100 Canadians were diagnosed with CRC and 9400 died of the disease…
Anti-diabetes drugs may reduce the risk of colorectal cancer
At a Glance
People with diabetes who took drugs called GLP-1 receptor agonists had a lower risk of colorectal cancer compared with those prescribed other diabetes drugs.
More research is needed to understand how GLP-1 receptor…
Accelerating Colorectal Cancer Screening and Follow-up Through Implementation Science
Samir Gupta, MD, MSCS1,2; Autumn Barnes3; Alison T. Brenner4,5; Janis Campbell6; Melinda Davis, PhD, MCR7; Kevin English, DrPH8; Sonja Hoover, MPP3; Karen Kim, MD, MS9; Sarah Kobrin, PhD, MPH10; Peter Lance, MD11; Shiraz I.…
Black-White Disparities in Colorectal Cancer Outcomes
The US Black population has higher colorectal cancer (CRC) incidence rates and worse CRC survival than the US White population, as well as historically lower rates of CRC screening. The Surveillance, Epidemiology, and End Results…
Disease of the Week – Colorectal Cancer
Of cancers affecting both men and women, colorectal cancer (cancer of the colon and rectum) is the second leading cancer killer in the United States, but it doesn’t have to be. Screening can find precancerous polyps—abnormal growths in…